This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?
by Benjamin Rains
Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $43.85 in the latest trading session, marking a -1.02% move from the prior day.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $43.74, moving -1.15% from the previous trading session.
Altria (MO) Down 2.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Altria (MO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RRPs, Price Hikes Likely to Light Up Tobacco Industry's Fate
by Vidya Nair
Regulatory headwinds are weighing on cigarette sales. However, tobacco players are gaining from price hikes and advancements in RRPs.
Company News for Aug 28, 2019
by Zacks Equity Research
Companies in the news are: SJM, MO, EV, BNS
Altria (MO) in Talks to Unite With Philip Morris, Stock Down
by Zacks Equity Research
Altria (MO) is in discussions with Philip Morris to consider the prospects of a merger. The companies have not revealed further information regarding the development.
Altria and Phillip Morris International in Merger Talks: What you Need to Know
by Mitchell Moore
On Tuesday, tobacco giants Altria (MO) and Philip Morris International (PM) announced discussions of a possible merger. The two companies stated that a deal has not yet been reached, but that it is possible and talks are underway.
The S&P 500's Wild August, HubSpot Stock & More - Free Lunch
by Benjamin Rains
A look at the S&P 500's wild August, GDP growth estimates and consumer confidence updates, Johnson & Johnson (JNJ) and news of a potential Philip Morris International (PM) and Altria (MO) merger, and why HubSpot (HUBS) is a Zacks Rank #1 (Strong Buy) stock - Free Lunch
Here's Why Philip Morris (PM) Stock is Down 4.7% in 3 Months
by Zacks Equity Research
Philip Morris (PM) witnesses receding cigarette sales volumes. Nevertheless, advancement in low-risk tobacco alternatives is encouraging.
ETFs in Focus as Consolidation Drives Marijuana Industry
by Sanghamitra Saha
Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.
Cronos (CRON) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on Cronos' (CRON) regular top and bottom-line numbers along with its pipeline progress when it reports second-quarter results.
Altria (MO) Q2 Earnings In Line, Smokeable Unit Aids Sales
by Zacks Equity Research
Altria (MO) reports in-line earnings in second-quarter 2019. It witnesses impressive top-line performance on robust revenues in the Smokeable Products business.
Altria (MO) Matches Q2 Earnings Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 0.00% and 2.88%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Altria (MO)
by Zacks Equity Research
Altria (MO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Cost Woes Hurt B&G Foods (BGS) This Earnings Season?
by Zacks Equity Research
Input costs related to freight and warehousing are likely to dent B&G Foods' (BGS) Q2 performance. Also, the Pirate Brands' divestiture is likely to dent sales.
Things You Need to Know Before Molson Coors' (TAP) Q2 Earnings
by Zacks Equity Research
Molson Coors' (TAP) second-quarter 2019 results are likely to remain bleak, thanks to soft volume, adverse currency and cost inflation. Tough beer industry is also likely to hurt results.
Kellogg's (K) Q2 Earnings Likely to be Hurt by Rising Costs
by Zacks Equity Research
Kellogg's (K) Q2 performance is likely to gain from strong brands. However, rising costs and currency headwinds are concerns.
What to Expect from Altria Earnings as MO Stock Continues to Struggle
by Mitchell Moore
Altria Group (MO) stock is up just 1.5% so far in 2019 to lag behind the tobacco market's nearly 16% climb. Let's see if we should expect this underperformance to continue following the release of Altria's earnings report before the market opens on Tuesday, July 30, or might MO shares get a boost.
Organic Sales to Boost Church & Dwight's (CHD) Q2 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2019 results are likely to gain from organic sales growth and prudent pricing moves.
Altria (MO) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Smokeless Unit & Pricing to Boost Altria's (MO) Q2 Earnings
by Zacks Equity Research
Altria's (MO) Q2 performance is likely to gain from RRPs, high pricing and saving initiatives.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $49.70, marking a -1.64% move from the previous day.
Things You Need to Know Before FEMSA's (FMX) Q2 Earnings
by Zacks Equity Research
FEMSA's (FMX) second-quarter 2019 results are likely to be impacted by ongoing cost headwinds, which should continue to hurt margins. However, its growth efforts might provide some respite.
Altria (MO) Stock Moves -0.26%: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $49.41, moving -0.26% from the previous trading session.